PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-9.23%
Negative revenue growth while NXPI stands at 3.21%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-17.32%
Negative gross profit growth while NXPI is at 0.13%. Joel Greenblatt would examine cost competitiveness or demand decline.
17.79%
Positive EBIT growth while NXPI is negative. John Neff might see a substantial edge in operational management.
17.79%
Positive operating income growth while NXPI is negative. John Neff might view this as a competitive edge in operations.
40.61%
Positive net income growth while NXPI is negative. John Neff might see a big relative performance advantage.
36.36%
Positive EPS growth while NXPI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
36.36%
Positive diluted EPS growth while NXPI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-6.67%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-6.67%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
7.15%
Dividend growth above 1.5x NXPI's 0.12%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-43.00%
Negative OCF growth while NXPI is at 37.88%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-90.98%
Negative FCF growth while NXPI is at 94.26%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-22.52%
Negative 10Y revenue/share CAGR while NXPI stands at 79.10%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-30.24%
Negative 5Y CAGR while NXPI stands at 77.31%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-18.27%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
23879.66%
10Y OCF/share CAGR above 1.5x NXPI's 104.58%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
98.23%
5Y OCF/share CAGR is similar to NXPI's 107.18%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
-44.59%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
26.28%
Net income/share CAGR at 50-75% of NXPI's 36.73%. Martin Whitman might question if the firm’s product or cost base lags behind.
27.72%
Below 50% of NXPI's 328.95%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-166.64%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
283.66%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
154.84%
5Y equity/share CAGR above 1.5x NXPI's 18.89%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
78.94%
3Y equity/share CAGR above 1.5x NXPI's 42.98%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-68.64%
Cut dividends over 10 years while NXPI stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
1.81%
Below 50% of NXPI's 169.49%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
1.65%
Below 50% of NXPI's 20.43%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-13.03%
Firm’s AR is declining while NXPI shows 1.04%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-16.82%
Inventory is declining while NXPI stands at 0.47%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-8.73%
Negative asset growth while NXPI invests at 0.28%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.32%
We have a declining book value while NXPI shows 3.20%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
1.53%
We have some new debt while NXPI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-13.11%
Our R&D shrinks while NXPI invests at 4.75%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-22.00%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.